Longevity & AgingGDF-15 fails to predict bleeding risk in patients on anticoagulation for blood clots
GDF-15, a stress-response protein that rises with age and disease, has been proposed as a marker for bleeding risk on blood thinners. Researchers in Vienna tested this in 383 adults with acute pulmonary embolism or deep vein thrombosis, excluding people with active cancer and pregnant or peripartum patients. They measured GDF-15 at baseline and 3 months and followed participants for up to 2 years. Forty-nine patients had a first clinically relevant bleed, a 1-year cumulative incidence of 11.9%. Baseline GDF-15 was not associated with bleeding, even after adjusting for age, sex, and bleeding history. Adding it to the VTE-PREDICT bleeding score did not meaningfully improve prediction. The ABC-bleeding score, which includes GDF-15, showed only modest discrimination. In this younger, cancer-free population, GDF-15 does not appear useful for bleeding risk assessment.